Trials / Completed
CompletedNCT01104181
Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test
Collection of Anal Specimens for Assessment of Anal Cancer Using the HC2 High-Risk DNA Test (QIAGEN)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Laser Surgery Care · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to determine if HC2 HPV testing in the anal canal can detect high-risk HPV and whether this aids in identifying individuals are risk for anal cancer or precancerous lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HC2 collection kit with a swab or brush | We will sample the anal canal for cells with either a swab and swab or swab and brush to determine which is superior |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-12-01
- Completion
- 2011-03-01
- First posted
- 2010-04-15
- Last updated
- 2011-06-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01104181. Inclusion in this directory is not an endorsement.